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Abstract
Nanoparticles of metal oxides are widely used in bionanotechnology, particularly in bio-medical applications; e.g., construction
of biosensors, separation of biological materials, molecular imaging, and anticancer and antimicrobial therapies. However,
synthesis of these nanoparticles using physico-chemical methods is problematic, because such procedures require high-tem-
perature processes and harsh chemical treatments. The use of peptides specifically binding particular nanoparticles or nano-
structures and facilitating their synthesis appears to be an encouraging alternative. Specific peptides capable of such reactions
may be identified with the use of the phage display method. In this mini-review, zinc oxide is discussed as an exemple material
whose nanoparticles can be bound and synthesized by such peptides exposed on the surface of bacteriophage capsids. An ana-
lysis of reports on studies into methods of peptide-aided synthesis of ZnO nanoparticles has indicated that, despite the
encouraging results obtained so far, further studies are necessary to optimize such procedures. This may also be true for
nanoparticles of other materials, particularly metal oxides.
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Introduction: nanomaterials 
and bionanotechnology
Nanotechnology is a rapidly developing field based on
the use of particles of various materials whose size, in at
least one dimension, is between 1 and 100 nm. Nano-sized
materials often have physical and chemical properties that
are substantially different from the same materials at
larger scales. Useful in diverse fields such as physics and
chemistry, nanomaterials appear to be principally appli-
cable in biology and medicine (Whitesides, 2003). Em-
ployment of nanomaterials in bio-medical applications
(such as construction of biosensors, separation of bio-
logical materials, molecular imaging, anticancer and anti-
microbial therapies, and others), as well as the use of
biological systems to synthesize or isolate nanoparticles
and nanostructures, is referred to as bionanotechnology
(de Morais et al., 2014; Schrofel et al., 2014).
The applications of nanotechnology are extremely
wide-ranging and include microelectronics, textiles,
energy production, novel therapies and diagnostic tools,
or new generation cosmetics (McIntyre, 2012). On the
other hand, while initial works had suggested that nano-
materials are generally safe for most organisms, inclu-
ding humans, more recent studies have signaled the
possible toxicity of at least some nanoparticles (Wiesen-
thal et al., 2011; Win-Shwe and Fujimaki, 2011; Nohynek
and Dufour, 2012; Wang et al., 2013; Migliore et al.,
2015). The aim of this review article is not, however, to
discuss the whole field of nanotechnology or bionano-
technology or their advances and limitations. Rather, we
will focus on a single nanomaterial, zinc oxide, and will
review the progress in the synthesis of ZnO nanoparti-
cles with the use of peptide sequences, identified as
a bio-template by a biological system called phage dis-
play. This, however, can be treated as an example of bio-
nanotechnological applications, and the indicated impli-
cations may be considered in a broader context. 
Zinc oxide as one of the elite nanomaterials
Zinc oxide is one of most widely used nanomaterials.
Recently, it has been included within the elite group of
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nanomaterials, together with graphene, carbon nanotu-
bes and gold (Kumar et al., 2015). Of particular interest
is the use of ZnO nanoparticles in the development of
novel biosensors (Yakimova et al., 2012), bioimaging, and
drug delivery (Xiong, 2013). In fact, ZnO reveals favorable
pharmacokinetic features, though detailed parameters
depend on several factors, such as particle size, surface
charge, surface coating, protein binding, exposure route
and dose (Lin et al., 2015). As zinc oxide nanoparticles
can act as effective filters of UV light, they are employed
as compounds in modern cosmetics, particularly those
used as sunscreens (Loh and Dunn, 2012). In the era of
the antibiotic crisis (Hansen et al., 2015), there is a new
hope that bacterial infections will be combated with the
use of ZnO nanoparticles. Such nano-sized materials have
been found to possess a potent antibacterial activity, and
since they are produced as artificial bodies, it is hoped
that development of resistance to them will not be as
obvious as it is to natural compounds (Pelgrift and Fried-
man, 2013). It appears that the size of ZnO particles,
which is within nanoscale, is crucial for their efficient
antibacterial activity (Dizaj et al., 2014). One mechanism
of their antibacterial activity is the induction of reactive
oxygen species formation (Shi et al., 2014), enhanced
after UV light absorption (Lipovsky et al., 2013).
Apart from the many encouraging or even enthusia-
stic reports indicating the wide-ranging applicability of
ZnO nanoparticles, as well as early reports suggesting
their safety (summarized by Nohynek et al., 2007), more
recent studies have revealed that this metal oxide, like
other similar compounds, may exert toxicity to eukary-
otic cells when acting in the nanoscale size range, as op-
posed to bulk ZnO powder (Reddy et al., 2007). Among
eukaryotes, algae have been found to be the most sensi-
tive organisms – crustaceans and fish being less sus-
ceptible – and toxicity to mammalian cells has been pro-
ved to be the lowest, although still considerable (Bonda-
renko et al., 2013). These differences are likely due to
organism-specific uptake of nanoparticles by cells, and
different efficiencies in oxidative stress induction (Ivask
et al., 2014). In the light of the potential toxicity of ZnO
nanoparticles to humans, the most worrisome are those
reports indicating that such particles may impair the im-
mune response (Roy et al., 2015) and provoke neuro-
degeneration (Migliore et al., 2015). 
Since the use of ZnO nanoparticles brings both new
hope for bionanotechnology and some apprehensions re-
garding their safety, it is clear that further extensive stu-
dies on these compounds are necessary. To this end,
efficient methods for their synthesis and isolation are
indispensable. 
Methods for the synthesis and isolation 
of ZnO nanoparticles
There are various physico-chemical methods to pro-
duce ZnO nanostructures, including methods based on
the sol-gel route (Tokumoto et al., 2003) or a simple so-
lution route (Yu et al., 2007), sonochemical synthesis
(Yu et al., 2015), hydrothermal synthesis (Chen et al.,
2007), microwave-assisted synthesis in benzyl alcohol
(Bilecka et al., 2009), self-propagating high-temperature
synthesis (Hwang et al., 2009), and the growth of crys-
tals in molten hydrous alkali solutions (Zhang et al.,
2011). However, such methods are sometimes either not
sufficiently efficient or too expensive, or they suffer from
contamination with toxic chemicals used in the techno-
logical processes. Furthermore, ZnO nanoparticles obtai-
ned as a final product may display low stability or under-
go the processes of self-aggregation. Therefore, alter-
native methods based on the use of biological systems
are currently considered an eco-friendly, cost-effective,
and contamination-free alternative (Żelechowska, 2014;
Hussain et al., 2015).
In the simplest of the systems, biological materials
have been proposed to facilitate ZnO nanoparticle syn-
thesis (Żelechowska, 2014; Madhumitha et al., 2016).
Examples include the use of collagen (Bai et al., 2009),
bacteriophage λ DNA (Atanasova et al., 2009), orange
juice (Jha et al., 2011), Ocimum basilicum (Salam et al.,
2014), Sargassum myriocystum (Nagarajan and Kuppu-
samy, 2013), or various microbes (Jayaseelan et al.,
2012; Hulkoti and Taranath, 2014). More advanced bio-
technological applications appear to be more specific,
reproducible and potentially useful in technological pro-
cesses. In particular, the discovery that various mate-
rials of non-biological origin, such as metals and their
derivatives, can be specifically bound by peptides of cha-
racteristic sequences has allowed researchers to develop
methods which employ genetic engineering and bioche-
mical techniques for material fabrication approaches
(Whaley et al., 2000). The phage display method, origi-
nally introduced by Smith (1985), seems to be the best
choice for the identification of peptide sequences for
such purposes. This method is based on the construc-
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Fig. 1. Scheme for the identification and isolation of bacterio-
phages binding ZnO nanoparticles (ZnO NPs) due to exposition 
of specific peptides on capsids 
tion of recombinant bacteriophages (i.e. viruses infecting
bacterial cells) which bear one of the genes coding for
capsid proteins fused to a foreign DNA fragment en-
coding a peptide of a specific sequence. As a result, after
propagation of the recombinant bacteriophage (phage)
in the host bacterial cells, such a peptide is exposed on
the virion (i.e. phage particle) surface. When a genetic
library composed of bacteriophages bearing a battery of
different DNA fragments, coding for various peptides
and fused to the capsid protein-encoding gene, is con-
structed, a vast number of peptide sequences can be
screened for particular purposes, including the binding
of metal oxides or the synthesis of nanoparticles (El-
dridge and Weiss, 2015). A scheme for the identification
and isolation of recombinant bacteriophages, exposing (on
their surfaces) peptides capable of binding particular ma-
terials (e.g. ZnO nanoparticles), is presented in Fig. 1.
Phage display-aided selection of ZnO-binding
peptides and synthesis of nanoparticles
In the first study devoted to isolating ZnO-binding
peptides, a library of random peptides was not exposed
on bacteriophage capsids, but on bacterial fimbriae
– FimH (Kjaergaard et al., 2000). This approach led to
the identification of several ZnO-binding peptides, of
which RSNTRMTAROHRSANHKSTQRARS had the
strongest affinity and specificity for ZnO. In fact, based
on this peptide, subsequent studies aimed at exposing
the zinc oxide-binding protein on the surface of a baculo-
viral capsid (Song et al., 2010a) for detection of chemical
composition defects and crystallographic state defects
(Vreuls et al., 2010), and the synthesis of ZnO nano-
particles (Song et al., 2010b).
The concept of using ZnO-binding peptides to pro-
duce nanoparticles had, in fact, been proposed earlier by
Umetsu et al. (2005). With the use of bacteriophages
displaying random 12-mer peptides fused to a minor coat
protein (pIII) of the M13 phage, this group identified
a ZnO-binding peptide (EAHVMHKVAPRP) and demon-
strated room-temperature immobilization and minerali-
zation of zinc oxide. Intriguingly, in their approach, the
authors finally used a modified, chemically synthesized
ZnO-binding peptide to which a glycine linker (GGGS)
and a cysteine residue at the C-terminus had been ad-
ded, facilitating the homogeneous creation of highly-or-
dered, flower-like structures composed of ZnO nanoparti-
cles with diameters of about 10 nm (Umetsu et al.,
2005). In 2011, the same group observed morphology
changes in ZnO structures when a ZnO-binding peptide
was used in the presence of dipeptides (M-H or H-K) for
ZnO NP synthesis (Togashi et al., 2011). 
Umetsu et al. (2005) was followed by other studies
aimed at synthesizing ZnO nanoparticles in reactions
facilitated by a peptide identified with the use of a phage
display technique. Tomczak et al. (2009) reported the
growth of ZnO hexagonal nanocrystals in the presence
of a chemically synthesized peptide (GLHVMHKVAPPR)
conjugated with the GGGSC tail and selected with the
use of the phage display method. The authors used
Zn(NO3)2 and 1,3-hexamethylenetetramine (HMTA) as
precursors in the Zn(NO3)2 @6H2O-HTMA system, and
carried out the reaction at 65EC for three days. Interes-
tingly, by altering the concentration of the peptide, ZnO
nanocrystal morphology could be tailored. This was done
by decreasing concentrations of the ZnO-binding peptide
which resulted in the elongation of ZnO nanoparticles,
while their hexagonal character was retained (Tomczak
et al., 2009). 
Based on peptide sequences identified by Umetsu
et al. (2005) and Tomczak et al. (2009), the Perry re- 
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Table 1. Sequences of ZnO-binding peptides
Amino acid sequence Reference
RSNTRMTAROHRSANHKSTQRARS
Kjaergaard et al. (2000) 
Song et al. (2010a)
Song et al. (2010b)
EAHVMHKVAPRP Umetsu et al. (2005)
QNTATAVSRLSP Umetsu et al. (2005)
ATHTNQTHALYR Umetsu et al. (2005)
VSNHKALDYPTR Umetsu et al. (2005)
DSGRYSMTNHYS Umetsu et al. (2005)
GLHVMHKVAPPR Tomczak et al. (2009)
VRTRDDARTHRK Vreuls et al. (2010)
HVNLHS Okochi et al. (2010a)
RCARRY Okochi et al. (2010a)
HYQSNW Okochi et al. (2010a)
HWFHPR Okochi et al. (2010a)
GAMHLPWHMGTL Wei et al. (2011)
TMGANLGLESPE Golec et al. (2012)
TMGANLGLKWPV Golec et al. (2012)
HSXXH Rothenstein et al. (2012)
VPGAAEHT Moon et al. (2015)
group carried out Zn(NO3)2 @6H2O-HTMA-dependent syn-
thesis of ZnO structures with modified morphology
(Liang et al., 2011; Limo et al., 2015; Sola-Rabada et al.,
2015). An attempt to obtain ZnO nanoparticles at room
temperature using another phage-display selected pep-
tide was reported subsequently (Wei et al., 2011). Re-
cently, Moon et al. (2015) employed a M13 phage dis-
play library with a 8-mer peptide fused to a pVIII phage
coat protein. They carried out a synthesis of micrometer
ZnO structures with the use of the Zn(NO3)2 @6H2O-
HTMA system and the ZnO-binding peptide bearing
a GGGSC linker (Moon et al., 2015).
There have been studies aimed at determining the
specific amino acid residues responsible for direct inter-
actions with ZnO. In the case of EAHVMHKVAPRP,
ZnO-binding peptide (Umetsu et al., 2005) sequences es-
sential for direct contact with this material were identi-
fied as HVMHKV and HKVAPR (Okochi et al., 2010b).
The same research group fused a recombinant green fluo-
rescent protein (GFP) to a ZnO-binding peptide, which
allowed the identification of a “hot spot” (EAHVMHK)
with the highest affinity for ZnO (Yokoo et al., 2010).
Additionally, based on these results, 420 chemically syn-
thesized random 6-mer peptides have been screened to
isolate specific ZnO-binding peptides (Okochi et al.,
2010a), revealing four alternating sequences: HVNLHS,
RCARRY, HYQSNW and HWFHPR, which display a slight-
ly weaker affinity for ZnO. Even more advanced investi-
gations have led to the determination of the HSXXH
sequence responsible for specific binding of ZnO (Ro-
thenstein et al., 2012). However, both the previously
mentioned reports (Kjaergaard et al., 2000; Umetsu
et al., 2005; Tomczak et al., 2009; Okochi et al., 2010a;
Okochi et al., 2010b; Wei et al., 2011), as well as a study
demonstrating a phage display-facilitated isolation of
novel peptides capable of binding ZnO and synthesizing
nanoparticles of this material (Golec et al., 2012), indi-
cated that the HSXXH motif is not necessary for efficient
ZnO binding (Table 1). On the contrary, it seems that
there is a huge variability of peptide sequences that can
efficiently bind ZnO. Moreover, some peptides can them-
selves be used for an effective synthesis of ZnO nano-
particles. Thus, it has been proposed that the distinct
properties of particular ZnO-binding peptides may be 
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Fig. 2. Examples of ZnO nanoparticles bound by bacterio-
phages exposing specific peptides on their capsids. A scanning
electron micrograph, taken with bacteriophage M13 exposing
the ZnO-binding peptide, described by Golec et al. (2012);
the bar represents 500 nm. The micrograph was provided
by Dr. Kamila Żelechowska (with permission)
crucial under specific conditions (Golec et al., 2012).
If this is true, one might speculate that peptides of va-
rious sequences might be optimal for different applica-
tions. Hence, identification of many variants of ZnO-bin-
ding peptides should not be considered an overabun-
dance of slightly different variants of the same tool, but
rather they may be recognized as a chance for the em-
ployment of alternative tools to achieve different goals in
studies into many applications of ZnO nanoparticles. 
Examples of ZnO nanoparticles bound by peptides
exposed on bacteriophage capsids are shown in Fig. 2.
Synthesis of ZnO nanoparticles with the use of chemi-
cally obtained peptides (whose sequences have pre-
viously been determined by the phage-display technique)
may result in the aggregation of these nanoparticles.
However, the results shown in Fig. 2 indicate that this is
not the case when peptides are still exposed on the
surface of bacteriophages, and nanoparticle synthesis
occurs on virions. Even if the structures are complex,
they are composed of separate nanoparticles of ZnO
(Fig. 2).
Concluding remarks
The employment of peptides specifically binding
ZnO, and selected with the use of the phage display
method, appears to be an encouraging alternative for the
synthesis of nanoparticles. This approach may have
a high level of impact on bionanotechnological applica-
tions, as zinc oxide nanomaterials are widely used in bio-
medicine. Further development of novel biosensors,
diagnostic tools, and therapies based on such materials
is within reach. It is interesting that papers describing
the identification of novel ZnO-binding peptides are
relatively rare in the literature, while – at the same time
– the synthesis of ZnO nanoparticles at room tempera-
ture and in the absence of harsh chemical procedures is
still far from satisfactory. ZnO-binding peptides provide
the basis for developing an inexpensive and eco-friendly
method for such synthesis which can also be free from
chemical contaminations. However, further research on
the optimization of both peptide sequences and reaction
conditions is necessary to achieve this goal. This may
also be true for nanoparticles of other materials, parti-
cularly metal oxides.
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